321

Novo Nordisk President and CEO Mike Doustdar says Christmas has come early with US approval of its Wegovy weight loss pill. He says the company is going "all-in" and they are super excited to be the first to market. Novo says the pill will go on sale in early January and be widely available. Doustdar speaks to Bloomberg's Katie Greifeld on "Bloomberg Surveillance." (Source: Bloomberg)
Be respectful and constructive. Comments are moderated.

No comments yet.